{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:03:30Z","timestamp":1789470210077,"version":"build-2803163510"},"reference-count":26,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2026.2189","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:16:31Z","timestamp":1786608991000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Tafolecimab mitigates ox\u2011LDL\u2011induced macrophage foam cell formation and inflammation by modulating SR\u2011A\/ABCG1 expression and inhibiting the NF\u2011\u03baB\/MAPK pathways"],"prefix":"10.3892","volume":"25","author":[{"given":"Xinyi","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510645, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, Guangdong 510623, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanye","family":"Dang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Target and Clinical Pharmacology, The Affiliated Traditional Chinese Medicine Hospital, NMPA and State Key Laboratory of Respiratory Diseases, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510645, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"key20260915131004_b1-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/ATVBAHA.123.319932","article-title":"Subclinical atherosclerosis: Part 1: What is it? Can it be defined at the histological level?","volume":"44","author":"Kawai","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20260915131004_b2-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","article-title":"Regulation of macrophage immunometabolism in atherosclerosis","volume":"19","author":"Koelwyn","year":"2018","journal-title":"Nat Immunol"},{"issue":"1185587","key":"key20260915131004_b3-BR-25-4-02189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1185587","article-title":"Macrophage polarization states in atherosclerosis","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"key20260915131004_b4-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1161\/CIRCRESAHA.123.323156","article-title":"Gs\u03b1 regulates macrophage foam cell formation during atherosclerosis","volume":"134","author":"Ma","year":"2024","journal-title":"Circ Res"},{"key":"key20260915131004_b5-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"49982","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages","volume":"277","author":"Kunjathoor","year":"2002","journal-title":"J Biol Chem"},{"key":"key20260915131004_b6-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.122.061620","article-title":"Long-term evolocumab in patients with established atherosclerotic cardiovascular disease","volume":"146","author":"O'Donoghue","year":"2022","journal-title":"Circulation"},{"key":"key20260915131004_b7-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"e1046","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: Executive summary: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"key20260915131004_b8-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"key20260915131004_b9-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"key20260915131004_b10-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s40265-023-01952-y","article-title":"Tafolecimab: First approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"key20260915131004_b11-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1001\/jamacardio.2021.1994","article-title":"Myocardial infarction and evolocumab","volume":"6","author":"White","year":"2021","journal-title":"JAMA Cardiol"},{"key":"key20260915131004_b12-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.4997\/JRCPE.2017.212","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"5392375","key":"key20260915131004_b13-BR-25-4-02189","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5392375","article-title":"The signaling pathways involved in the antiatherosclerotic effects produced by Chinese herbal medicines","volume":"2018","author":"Lu","year":"2018","journal-title":"BioMed Res Int"},{"issue":"108480","key":"key20260915131004_b14-BR-25-4-02189","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108480","article-title":"Targeting PCSK9 to tackle cardiovascular disease","volume":"249","author":"Hummelgaard","year":"2023","journal-title":"Pharmacol Ther"},{"key":"key20260915131004_b15-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.7150\/ijbs.91957","article-title":"Endothelial dickkopf-1 promotes smooth muscle cell-derived foam cell formation via USP53-mediated deubiquitination of SR-A during atherosclerosis","volume":"20","author":"Liu","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"123836","key":"key20260915131004_b16-BR-25-4-02189","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123836","article-title":"Scavenger receptor a mediates glycated LDL transcytosis across endothelial cells to promote atherosclerosis","volume":"235","author":"Cheng","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"105639","key":"key20260915131004_b17-BR-25-4-02189","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105639","article-title":"Yin-xing-tong-mai decoction attenuates atherosclerosis via activating PPAR\u03b3-LXR\u03b1-ABCA1\/ABCG1 pathway","volume":"169","author":"Zheng","year":"2021","journal-title":"Pharmacol Res"},{"key":"key20260915131004_b18-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.7150\/thno.26193","article-title":"Sonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPAR\u03b3-LXR\u03b1-ABCA1\/ABCG1 pathway and promotes cholesterol efflux in advanced plaque","volume":"8","author":"Wang","year":"2018","journal-title":"Theranostics"},{"key":"key20260915131004_b19-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1124\/pr.119.017897","article-title":"Brothers in arms: ABCA1- and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment","volume":"72","author":"Frambach","year":"2020","journal-title":"Pharmacol Rev"},{"issue":"102704","key":"key20260915131004_b20-BR-25-4-02189","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102704","article-title":"Acetylation of p65Lys310 by p300 in macrophages mediates anti-inflammatory property of berberine","volume":"62","author":"Zhang","year":"2023","journal-title":"Redox Biol"},{"key":"key20260915131004_b21-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell Mol Immunol"},{"issue":"1529756","key":"key20260915131004_b22-BR-25-4-02189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1529756","article-title":"Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways","volume":"16","author":"Kaszycki","year":"2025","journal-title":"Front Immunol"},{"key":"key20260915131004_b23-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3724\/abbs.2024008","article-title":"Gallic acid attenuates LPS-induced inflammation in Caco-2 cells by suppressing the activation of the NF-\u03baB\/MAPK signaling pathway","volume":"56","author":"Chu","year":"2024","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"116613","key":"key20260915131004_b24-BR-25-4-02189","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116613","article-title":"Yohimbine treatment improves pulmonary fibrosis by attenuating the inflammation and oxidative stress via modulating the MAPK pathway","volume":"230","author":"Kambhampati","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"key20260915131004_b25-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/endrev\/bnab035","article-title":"The multifaceted biology of PCSK9","volume":"43","author":"Seidah","year":"2022","journal-title":"Endocr Rev"},{"key":"key20260915131004_b26-BR-25-4-02189","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/ATVBAHA.123.320391","article-title":"Disruption of PCSK9 suppresses inflammation and attenuates abdominal aortic aneurysm formation","volume":"45","author":"Peng","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:10:06Z","timestamp":1789467006000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2026.2189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2026.2189","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}